Cargando…

Cranial Reconstruction following the Removal of an Infected Synthetic Dura Mater Substitute

BACKGROUND: The objective of this study was to describe the outcomes of an algorithmic approach to cranial reconstruction following the removal of an infected synthetic dura mater substitute due to postcraniotomy infection. METHODS: A retrospective review was conducted of the cases of 12 patients wh...

Descripción completa

Detalles Bibliográficos
Autor principal: Yoshioka, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174208/
https://www.ncbi.nlm.nih.gov/pubmed/25289327
http://dx.doi.org/10.1097/GOX.0000000000000087
_version_ 1782336325949587456
author Yoshioka, Nobutaka
author_facet Yoshioka, Nobutaka
author_sort Yoshioka, Nobutaka
collection PubMed
description BACKGROUND: The objective of this study was to describe the outcomes of an algorithmic approach to cranial reconstruction following the removal of an infected synthetic dura mater substitute due to postcraniotomy infection. METHODS: A retrospective review was conducted of the cases of 12 patients who underwent cranial reconstruction from 2006 to 2013 after the removal of an infected expanded polytetrafluoroethylene sheet (a synthetic dura mater substitute) due to postcraniotomy infection. RESULTS: Average patient age was 46 years (range, 19–70 years). Follow-up was 4.6 years. The expanded polytetrafluoroethylene sheets were implanted after decompressive craniectomy or after combined resection of the dura mater and a tumor. Epidural, but not subdural, abscesses were found in 6 patients, in whom a sufficient capsule developed underneath the synthetic dura mater. Both epidural and subdural abscesses were found in the remaining 6 patients, and the capsule remained intact after debridement of the subdural abscesses in half of them. Secondary cranial reconstruction was safely performed by leaving the capsule intact in the 9 cases in which no additional dural reconstruction was performed. In the remaining 3 patients, in whom no capsule remained after debridement, secondary cranial reconstruction was carried out by leaving the pericranium over the brain surface. None of the patients developed postoperative complications in follow-up periods. CONCLUSIONS: Staged cranial reconstruction after the removal of an infected synthetic dura mater substitute using an algorithmic approach is feasible and safe, produces satisfactory cosmetic results, and is not associated with any complications.
format Online
Article
Text
id pubmed-4174208
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-41742082014-10-06 Cranial Reconstruction following the Removal of an Infected Synthetic Dura Mater Substitute Yoshioka, Nobutaka Plast Reconstr Surg Glob Open Original Articles BACKGROUND: The objective of this study was to describe the outcomes of an algorithmic approach to cranial reconstruction following the removal of an infected synthetic dura mater substitute due to postcraniotomy infection. METHODS: A retrospective review was conducted of the cases of 12 patients who underwent cranial reconstruction from 2006 to 2013 after the removal of an infected expanded polytetrafluoroethylene sheet (a synthetic dura mater substitute) due to postcraniotomy infection. RESULTS: Average patient age was 46 years (range, 19–70 years). Follow-up was 4.6 years. The expanded polytetrafluoroethylene sheets were implanted after decompressive craniectomy or after combined resection of the dura mater and a tumor. Epidural, but not subdural, abscesses were found in 6 patients, in whom a sufficient capsule developed underneath the synthetic dura mater. Both epidural and subdural abscesses were found in the remaining 6 patients, and the capsule remained intact after debridement of the subdural abscesses in half of them. Secondary cranial reconstruction was safely performed by leaving the capsule intact in the 9 cases in which no additional dural reconstruction was performed. In the remaining 3 patients, in whom no capsule remained after debridement, secondary cranial reconstruction was carried out by leaving the pericranium over the brain surface. None of the patients developed postoperative complications in follow-up periods. CONCLUSIONS: Staged cranial reconstruction after the removal of an infected synthetic dura mater substitute using an algorithmic approach is feasible and safe, produces satisfactory cosmetic results, and is not associated with any complications. Wolters Kluwer Health 2014-05-07 /pmc/articles/PMC4174208/ /pubmed/25289327 http://dx.doi.org/10.1097/GOX.0000000000000087 Text en Copyright © 2014 The Authors. Published by Lippincott Williams & Wilkins on behalf of The American Society of Plastic Surgeons. PRS Global Open is a publication of the American Society of Plastic Surgeons. http://creativecommons.org/licenses/by-nc-nd/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Original Articles
Yoshioka, Nobutaka
Cranial Reconstruction following the Removal of an Infected Synthetic Dura Mater Substitute
title Cranial Reconstruction following the Removal of an Infected Synthetic Dura Mater Substitute
title_full Cranial Reconstruction following the Removal of an Infected Synthetic Dura Mater Substitute
title_fullStr Cranial Reconstruction following the Removal of an Infected Synthetic Dura Mater Substitute
title_full_unstemmed Cranial Reconstruction following the Removal of an Infected Synthetic Dura Mater Substitute
title_short Cranial Reconstruction following the Removal of an Infected Synthetic Dura Mater Substitute
title_sort cranial reconstruction following the removal of an infected synthetic dura mater substitute
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174208/
https://www.ncbi.nlm.nih.gov/pubmed/25289327
http://dx.doi.org/10.1097/GOX.0000000000000087
work_keys_str_mv AT yoshiokanobutaka cranialreconstructionfollowingtheremovalofaninfectedsyntheticduramatersubstitute